For a stock which is held by so few and is characterised by....

For a stock which is held by so few and is characterised by. super low volume - PO3 sure does seem to attract a fair amount of conflict on these forums. Much of this seems to be around just what PO3 is potentially bringing to market - and I think this is where management has failed over the last few years - and likely faces further challenges on a related level.

Firstly, I don't think they have yet to be able to establish the clear point of difference the technology is likely to offer the end user - what exactly is the value proposition that will attract business / consumer interest? I'm not saying FRG isn't 'superior' - I wouldn't know beyond what little PO3 has told the market. I'm just left unsure as to exactly why the broader market would be interested in the tech. If it is 'superior' - in what way? And by how much? And why does that matter? Pretty basic questions any company should be able to communicate - but not what PO3 has seemingly done so far.

Secondly - if they are able to establish a clear and differentiated value proposition - to what extent is there likely to be demand for it? And who will the main competitors be? There are air purification units that have been proven to eradicate COVID19. There are working and commercialised solutions for medical surface sterilisation (had to check my spelling there for a moment....). So how and why will FRG be different - and will that result in greater demand for the tech?

I'd just like to see a simple answer to the question "Why should consumers / businesses consider FRG ahead of existing solutions for air, water and surface sterilisation?"

I used to think I could answer that - but the day I found I couldn't do so with confidence was the day I started reducing my position. I hope this ends well for believers - there does seem to be a hint of something about this stock and its tech - I just can't get a handle on it myself.